Showing 1 - 7 results of 7 for search 'Keymeulen, B', query time: 0.02s
Refine Results
-
1
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients. by Alkemade, G, Hilbrands, R, Vandemeulebroucke, E, Pipeleers, D, Waldmann, H, Mathieu, C, Keymeulen, B, Roep, B
Published 2011Conference item -
2
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes. by Hale, G, Rebello, P, Al Bakir, I, Bolam, E, Wiczling, P, Jusko, W, Vandemeulebroucke, E, Keymeulen, B, Mathieu, C, Ziegler, A, Chatenoud, L, Waldmann, H
Published 2010Journal article -
3
Phase Ib clinical trial of IMCY-0098 in young adults with recent-onsent type 1 diabetes by Van Rampelbergh, J, Boitard, C, Achenbach, P, Leslie, RD, Dayan, C, Keymeulen, B, Owen, K, Lapauw, B, Carlier, V, Ahangarani, RR, Gebruers, E, Vanderelst, L, Van Mechelen, M, Vandepapeliere, P
Published 2019Conference item -
4
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. by Keymeulen, B, Walter, M, Mathieu, C, Kaufman, L, Gorus, F, Hilbrands, R, Vandemeulebroucke, E, Van de Velde, U, Crenier, L, De Block, C, Candon, S, Waldmann, H, Ziegler, A, Chatenoud, L, Pipeleers, D
Published 2010Journal article -
5
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. by Keymeulen, B, Candon, S, Fafi-Kremer, S, Ziegler, A, Leruez-Ville, M, Mathieu, C, Vandemeulebroucke, E, Walter, M, Crenier, L, Thervet, E, Legendre, C, Pierard, D, Hale, G, Waldmann, H, Bach, J, Seigneurin, J, Pipeleers, D, Chatenoud, L
Published 2010Journal article -
6
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. by Keymeulen, B, Vandemeulebroucke, E, Ziegler, A, Mathieu, C, Kaufman, L, Hale, G, Gorus, F, Goldman, M, Walter, M, Candon, S, Schandene, L, Crenier, L, De Block, C, Seigneurin, J, De Pauw, P, Pierard, D, Weets, I, Rebello, P, Bird, P, Berrie, E, Frewin, M, Waldmann, H, Bach, J, Pipeleers, D, Chatenoud, L
Published 2005Journal article -
7
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop by Rickels, MR, Stock, PG, De Koning, EJP, Piemonti, L, Pratschke, J, Alejandro, R, Bellin, MD, Berney, T, Choudhary, P, Johnson, PR, Kandaswamy, R, Kay, TWH, Keymeulen, B, Kudva, YC, Latres, E, Langer, RM, Lehmann, R, Ludwig, B, Markmann, JF, Marinac, M, Odorico, JS, Pattou, F, Senior, PA, Shaw, JAM, Vantyghem, M-C, White, S
Published 2018Journal article